FlowMed
Continuous Irrigation for Endoscopic Surgeries
Company Overview
Snapshot
Founded in December 2009 by Gil Tenenbaum, Dr. Leonid Lobik, and Ehood Nakash, FlowMed operated with 1–10 employees. The company raised $2M across one seed funding round from two investors. FlowMed ceased operations in January 2020.
Business overview
FlowMed developed a robotic system designed to provide continuous irrigation for surgical procedures that require a consistent, regulated flow of solution. The company's core product, Aqueduct, targets the medical devices industry, specifically hospitals and surgeons, by enhancing minimally-invasive endoscopic surgeries. Operating within the Health Tech & Life Sciences sector, FlowMed focused on medical treatment and therapeutics, leveraging machinery and robotics for automation in operating rooms.
Log in to access full profile ›Company Intelligence Q&A
- When was FlowMed founded and by whom?
- FlowMed was founded in December 2009 by Gil Tenenbaum, Dr. Leonid Lobik, and Ehood Nakash.
- What is FlowMed's primary product?
- FlowMed's primary product is Aqueduct, a robotic system that facilitates continuous irrigation for endoscopic surgeries.
- What was FlowMed's operational status?
- FlowMed ceased to operate in January 2020.
- How much capital did FlowMed raise?
- FlowMed raised a total of $2M in a seed funding round in January 2015.
- Which investors participated in FlowMed's funding round?
- In January 2015, FlowMed received funding from the Office of the Chief Scientist and hiCenter Ventures.